ARS Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRY and other ETFs, options, and stocks.

About SPRY

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray.

CEO

Richard E. Lowenthal

CEORichard E. Lowenthal

Employees

160

Employees160

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2015

Founded2015

Employees

160

Employees160

SPRY Key Statistics

Market cap

1.44B

Market cap1.44B

Price-Earnings ratio

184.12

Price-Earnings ratio184.12

Dividend yield

—

Dividend yield—

Average volume

1.53M

Average volume1.53M

High today

$15.46

High today$15.46

Low today

$14.20

Low today$14.20

Open price

$14.46

Open price$14.46

Volume

821.36K

Volume821.36K

52 Week high

$18.51

52 Week high$18.51

52 Week low

$7.55

52 Week low$7.55

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

ARS Pharmaceuticals

Why Robinhood?

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. Show more

SPRY Key Statistics

Analyst ratings

100%

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray.